Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to -$1.3 million.

  • Abvc Biopharma's Profit After Tax fell 16414.47% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year decrease of 384.0%. This contributed to the annual value of -$5.3 million for FY2024, which is 3649.15% up from last year.
  • Latest data reveals that Abvc Biopharma reported Profit After Tax of -$1.3 million as of Q3 2025, which was down 16414.47% from -$2.3 million recorded in Q2 2025.
  • Over the past 5 years, Abvc Biopharma's Profit After Tax peaked at -$487431.0 during Q3 2024, and registered a low of -$7.7 million during Q4 2021.
  • Its 5-year average for Profit After Tax is -$2.5 million, with a median of -$1.9 million in 2022.
  • In the last 5 years, Abvc Biopharma's Profit After Tax plummeted by 40928.62% in 2022 and then soared by 8552.79% in 2024.
  • Quarter analysis of 5 years shows Abvc Biopharma's Profit After Tax stood at -$7.7 million in 2021, then surged by 40.14% to -$4.6 million in 2022, then surged by 84.81% to -$700309.0 in 2023, then decreased by 13.74% to -$796527.0 in 2024, then crashed by 61.64% to -$1.3 million in 2025.
  • Its Profit After Tax was -$1.3 million in Q3 2025, compared to -$2.3 million in Q2 2025 and -$944190.0 in Q1 2025.